Concepedia

Jörg Eder

JE

Statistics

Publications

31

Citations

1.9K

H-Index

23

Active since

1972

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Max Planck Institute of Biochemistry

Cardiff University

Novartis (United States)

Jörg Eder is an author at Novartis (Switzerland) specializing in life sciences, molecular biology, and biochemistry.

ORCID

Publications per year

1972–2021

31

Publications

31

Small-molecule factor B inhibitor for the treatment of complement-mediated diseases

Anna Schubart, Karen Anderson, Nello Mainolfi et al. · Proceedings of the National Academy of Sciences · 2019 · 216 citations · Full text

, , +17

Targeted inhibition of the COP9 signalosome for treatment of cancer

Anita Schlierf, Eva Altmann, Jean Quancard et al. · Nature Communications · 2016 · 204 citations · Full text

, , +17

Crystal Structure of NLRP3 NACHT Domain With an Inhibitor Defines Mechanism of Inflammasome Inhibition

Carien Dekker, Henri Mattes, Michael Wright et al. · Journal of Molecular Biology · 2021 · 160 citations

, , +16

Design and preparation of 2-benzamido-pyrimidines as inhibitors of IKK

Rudolf Waelchli, Birgit Bollbuck, Christian Bruns et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 148 citations · Full text

, , +8

MAA868, a novel FXI antibody with a unique binding mode, shows durable effects on markers of anticoagulation in humans

Alexander W. Koch, Nikolaus Schiering, Samu Melkko et al. · Blood · 2019 · 122 citations · Full text

, , +16

1–5 of 31